Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy
Blood and Lymphatic Cancer: Targets and Therapy
An international, peer reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
- 5 records -
Seegobin K, Alhaj Moustafa M, Jiang L, Tun HW
Published Date: 22 September 2021
Pongas G, Cheson B
Published Date: 30 July 2021
Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence
Stemer G, Rowe JM, Ofran Y
Published Date: 22 June 2021
Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review
Bender C, Maese L, Carter-Febres M, Verma A
Published Date: 19 April 2021
Gupta VA, Ackley J, Kaufman JL, Boise LH
Published Date: 12 March 2021